ID DLL3_MOUSE Reviewed; 592 AA. AC O88516; O35675; Q80W06; Q9QWL9; Q9QWZ7; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1998, sequence version 1. DT 27-MAR-2024, entry version 188. DE RecName: Full=Delta-like protein 3; DE AltName: Full=Drosophila Delta homolog 3; DE Short=Delta3; DE Short=M-Delta-3; DE Flags: Precursor; GN Name=Dll3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=C57BL/6 X DBA; TISSUE=Embryo; RX PubMed=9272948; DOI=10.1242/dev.124.16.3065; RA Dunwoodie S.L., Henrique D.M.P., Harrison S.M., Beddington R.S.P.; RT "Mouse Dll3: a novel divergent Delta gene which may complement the function RT of other Delta homologues during early pattern formation in the mouse RT embryo."; RL Development 124:3065-3076(1997). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND INVOLVEMENT IN RP PU. RC STRAIN=129/SvJ; RX PubMed=9662403; DOI=10.1038/961; RA Kusumi K., Sun E.S., Kerrebrock A.W., Bronson R.T., Chi D.-C., RA Bulotsky M.S., Spencer J.B., Birren B.W., Frankel W.N., Lander E.S.; RT "The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of RT early somite boundaries."; RL Nat. Genet. 19:274-278(1998). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Neural tube; RA Nakayama K., Nakayama N., Tomooka Y., Hayashi Y., Takahashi M.; RT "Specific expression of a divergent type of Delta in a set of earliest RT generated neurons including the prospective subplate neurons."; RL Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Inhibits primary neurogenesis. May be required to divert CC neurons along a specific differentiation pathway. Plays a role in the CC formation of somite boundaries during segmentation of the paraxial CC mesoderm. CC -!- SUBUNIT: Can bind and activate Notch-1 or another Notch receptor. CC {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I CC membrane protein {ECO:0000305}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=2; CC IsoId=O88516-1; Sequence=Displayed; CC Name=1; CC IsoId=O88516-2; Sequence=VSP_001376; CC -!- TISSUE SPECIFICITY: Predominantly expressed in the neuroectoderm and CC paraxial mesoderm during embryogenesis. CC -!- DOMAIN: The DSL domain is required for binding to the Notch receptor. CC -!- PTM: Ubiquitinated by MIB (MIB1 or MIB2), leading to its endocytosis CC and subsequent degradation. {ECO:0000250}. CC -!- DISEASE: Note=A truncating mutation in Dll3 is the cause of the pudgy CC (pu) phenotype. Pudgy mice exhibit patterning defects at the earliest CC stages of somitogenesis. Adult pudgy mice present severe vertebral and CC rib deformities. {ECO:0000269|PubMed:9662403}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF068865; AAC40170.1; -; Genomic_DNA. DR EMBL; AF068865; AAC40169.1; -; Genomic_DNA. DR EMBL; Y11895; CAA72637.1; -; mRNA. DR EMBL; AB013440; BAA33716.1; -; mRNA. DR EMBL; BC052002; AAH52002.1; -; mRNA. DR CCDS; CCDS39856.1; -. [O88516-2] DR RefSeq; NP_031892.2; NM_007866.2. [O88516-2] DR AlphaFoldDB; O88516; -. DR SMR; O88516; -. DR BioGRID; 199233; 1. DR STRING; 10090.ENSMUSP00000103951; -. DR PhosphoSitePlus; O88516; -. DR MaxQB; O88516; -. DR PaxDb; 10090-ENSMUSP00000103951; -. DR ProteomicsDB; 279433; -. [O88516-1] DR ProteomicsDB; 279434; -. [O88516-2] DR ABCD; O88516; 8 sequenced antibodies. DR Antibodypedia; 30387; 619 antibodies from 32 providers. DR DNASU; 13389; -. DR Ensembl; ENSMUST00000108315.4; ENSMUSP00000103951.4; ENSMUSG00000003436.12. [O88516-2] DR GeneID; 13389; -. DR KEGG; mmu:13389; -. DR AGR; MGI:1096877; -. DR CTD; 10683; -. DR MGI; MGI:1096877; Dll3. DR VEuPathDB; HostDB:ENSMUSG00000003436; -. DR eggNOG; KOG1217; Eukaryota. DR GeneTree; ENSGT00940000162127; -. DR HOGENOM; CLU_033244_0_0_1; -. DR InParanoid; O88516; -. DR OMA; WSHPEDG; -. DR OrthoDB; 5475408at2759; -. DR PhylomeDB; O88516; -. DR TreeFam; TF351835; -. DR BioGRID-ORCS; 13389; 3 hits in 79 CRISPR screens. DR ChiTaRS; Dll3; mouse. DR PRO; PR:O88516; -. DR Proteomes; UP000000589; Chromosome 7. DR RNAct; O88516; Protein. DR Bgee; ENSMUSG00000003436; Expressed in presomitic mesoderm and 95 other cell types or tissues. DR ExpressionAtlas; O88516; baseline and differential. DR GO; GO:0010008; C:endosome membrane; TAS:Reactome. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0005112; F:Notch binding; ISO:MGI. DR GO; GO:0001709; P:cell fate determination; NAS:UniProtKB. DR GO; GO:0007386; P:compartment pattern specification; IMP:MGI. DR GO; GO:0001701; P:in utero embryonic development; NAS:UniProtKB. DR GO; GO:0048712; P:negative regulation of astrocyte differentiation; ISO:MGI. DR GO; GO:0050768; P:negative regulation of neurogenesis; IDA:MGI. DR GO; GO:0045746; P:negative regulation of Notch signaling pathway; ISO:MGI. DR GO; GO:0007399; P:nervous system development; NAS:UniProtKB. DR GO; GO:0007219; P:Notch signaling pathway; IBA:GO_Central. DR GO; GO:0048339; P:paraxial mesoderm development; IMP:MGI. DR GO; GO:0050769; P:positive regulation of neurogenesis; ISO:MGI. DR GO; GO:0001501; P:skeletal system development; IMP:UniProtKB. DR GO; GO:0001756; P:somitogenesis; IDA:MGI. DR GO; GO:0009888; P:tissue development; IDA:MGI. DR CDD; cd00054; EGF_CA; 5. DR Gene3D; 2.60.40.3510; -; 1. DR Gene3D; 2.10.25.10; Laminin; 6. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR013032; EGF-like_CS. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf. DR InterPro; IPR011651; Notch_ligand_N. DR PANTHER; PTHR24049; CRUMBS FAMILY MEMBER; 1. DR PANTHER; PTHR24049:SF22; DROSOPHILA CRUMBS HOMOLOG; 1. DR Pfam; PF00008; EGF; 3. DR Pfam; PF12661; hEGF; 2. DR Pfam; PF07657; MNNL; 1. DR PRINTS; PR00010; EGFBLOOD. DR SMART; SM00181; EGF; 6. DR SMART; SM00179; EGF_CA; 5. DR SUPFAM; SSF57196; EGF/Laminin; 2. DR SUPFAM; SSF57184; Growth factor receptor domain; 1. DR PROSITE; PS00022; EGF_1; 6. DR PROSITE; PS01186; EGF_2; 6. DR PROSITE; PS50026; EGF_3; 6. DR Genevisible; O88516; MM. PE 2: Evidence at transcript level; KW Alternative splicing; Developmental protein; Differentiation; KW Disulfide bond; EGF-like domain; Membrane; Notch signaling pathway; KW Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix; KW Ubl conjugation. FT SIGNAL 1..32 FT /evidence="ECO:0000255" FT CHAIN 33..592 FT /note="Delta-like protein 3" FT /id="PRO_0000007510" FT TOPO_DOM 33..490 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 491..511 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 512..592 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 174..213 FT /note="DSL" FT DOMAIN 214..247 FT /note="EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 272..308 FT /note="EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 310..349 FT /note="EGF-like 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 351..387 FT /note="EGF-like 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 389..425 FT /note="EGF-like 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 427..463 FT /note="EGF-like 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT REGION 548..567 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT DISULFID 218..229 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 222..235 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 237..246 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 276..287 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 281..296 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 298..307 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 314..325 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 319..337 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 339..348 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 355..366 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 360..375 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 377..386 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 393..404 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 398..413 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 415..424 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 431..442 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 436..451 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 453..462 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT VAR_SEQ 585..592 FT /note="DWLIQVLF -> A (in isoform 1)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:9272948, ECO:0000303|Ref.3" FT /id="VSP_001376" FT CONFLICT 94 FT /note="E -> K (in Ref. 3; BAA33716)" FT /evidence="ECO:0000305" FT CONFLICT 401 FT /note="G -> A (in Ref. 1; CAA72637)" FT /evidence="ECO:0000305" SQ SEQUENCE 592 AA; 62069 MW; 1A84F8022E7E7DCC CRC64; MVSLQVSPLS QTLILAFLLP QALPAGVFEL QIHSFGPGPG LGTPRSPCNA RGPCRLFFRV CLKPGVSQEA TESLCALGAA LSTSVPVYTE HPGESAAALP LPDGLVRVPF RDAWPGTFSL VIETWREQLG EHAGGPAWNL LARVVGRRRL AAGGPWARDV QRTGTWELHF SYRARCEPPA VGAACARLCR SRSAPSRCGP GLRPCTPFPD ECEAPSVCRP GCSPEHGYCE EPDECRCLEG WTGPLCTVPV STSSCLNSRV PGPASTGCLL PGPGPCDGNP CANGGSCSET SGSFECACPR GFYGLRCEVS GVTCADGPCF NGGLCVGGED PDSAYVCHCP PGFQGSNCEK RVDRCSLQPC QNGGLCLDLG HALRCRCRAG FAGPRCEHDL DDCAGRACAN GGTCVEGGGS RRCSCALGFG GRDCRERADP CASRPCAHGG RCYAHFSGLV CACAPGYMGV RCEFAVRPDG ADAVPAAPRG LRQADPQRFL LPPALGLLVA AGLAGAALLV IHVRRRGPGQ DTGTRLLSGT REPSVHTLPD ALNNLRLQDG AGDGPSSSAD WNHPEDGDSR SIYVIPAPSI YAREDWLIQV LF //